The loss of CV Sciences under GAAP for 9 months of 2020 amounted to $12.99 million, an increase of 30.9% compared to $9.924 million in the previous year. Revenues decreased by 56.7% to $19.23 million, against $44.368 million a year earlier.
The loss of CV Sciences under GAAP for 9 months of 2020 amounted to $12.99 million, an increase of 30.9% compared to $9.924 million in the previous year. Revenues decreased by 56.7% to $19.23 million, against $44.368 million a year earlier. 
ir.cvsciences.com
English (US) 